Therapeutic indications targeting etiology. (With the exception of primary progressive forms)
Brassat, D.
Revue Neurologique (Paris) 157(8-9 Part 2): 1014-1028
2001
ISSN/ISBN: 0035-3787 PMID: 11787332 Document Number: 534216
On the subject of the treatment of Multiple Sclerosis, JM Charcot stated in 1877 that "the time has not yet come when such a subject can be seriously considered". Fortunately such point of view is no more up to date. This chapter will review the available treatment for relapsing-remitting and secondary progressive Multiple Sclerosis. The immunosuppressive drugs and steroids have been used for many years. Immunomodulation appeared more recently. A review of the evidence on the use of those drugs will be performed.